EICHORCondition: Total Hip Arthroplasty (THA) · Sponsor: Societe dEtude, de Recherche et de Fabrication
XPEO-E liner is CE marked under MDD 93/42/CEE by equivalency with CI E liner. No pertaining data on XPEO-E liner is yet available. However, clinical evaluation concludes on a reaching of performance and safety and compliance with essential requirements. This study intends to collect data on XPEO-E in order to allow a transit to MDR 2017/745 (EU). XPEO-E liner is intended to be used with NOVAE cups and SERF femoral heads and Stems. XPEO-E liner will be used according to their CE marking. These devices are intended for hip replacements with the aim of improving quality of life and reducing pain by replacing a damaged joint. The follow-up visits are established according to the current practice. Additional procedure will only consist on questionnaires that will be filled by the patient and/or the surgeons.
This description comes directly from the study's public registry record.
Clinical department · +33472056010 · clinical@serf.fr
Always discuss trial participation with your own doctor first.
| CHU Dijon | Dijon, France | Recruiting |
| HCL Croix-Rousse | Lyon, France | Recruiting |
| HCL Lyon Sud | Lyon, France | Not Yet Recruiting |
| CHU Saint Etienne | Saint-Etienne, France | Recruiting |
| CHU Strasbourg | Strasbourg, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06917365